骨质疏松症大鼠注射重组人甲状旁腺素药动学研究
Pharmacokinetic study of the injection of recombinant human parathyroid hormone (1-84) in osteoporotic rats
投稿时间:2013-02-02  
DOI:
中文关键词:  注射用重组人甲状旁腺素rhPTH(1-84)  去卵巢骨质疏松症大鼠  药代动力学  放射免疫分析法
英文关键词:Recombinant human parathyroid hormones rhPTH (1-84) for injection  Ovariectomized osteoporosis rats  Pharmacokinetics  Radioimmunoassay
基金项目:康缘中医药科技创新基金(HZ1009KY);江苏省中医药领军人才(LJ2009002)
作者单位E-mail
王胜军 无锡市第九人民医院,江苏无锡,214063  
杨澔侠 无锡市第九人民医院,江苏无锡,214063  
张晶 南京中医药大学,南京,210005  
姚昶 江苏省中医院,南京,210029 yanchang67@126.com 
摘要点击次数: 1044
全文下载次数: 0
中文摘要:
      目的:研究注射用重组人甲状旁腺素rhPTH (1-84)在去卵巢骨质疏松症大鼠的药代动力学特征。方法48只大鼠(250±10)g,分成对照组(切除卵巢周围小块脂肪组织)和模型组(双侧卵巢切除),每组8只,手术4周后皮下注射1.0、2.0、4.0 ug/kg rhPTH(1-84),采用放射免疫分析法测定rhPTH(1-84)不同时间点的血药浓度,计算药代动力学参数。结果 rhPTH (1-84)在24~1850 pg/mL范围内线性关系良好,最低检测量为10 pg/mL;血浆提取回收率80.2%~90.6%;模型组低、中、高三个剂量的药动力学参数AUC(0-∞)分别为(24628.9±1281)、(47059.3±3311)和(96652.1±2174) ng/( L· min);对照组AUC(0-∞)分别为(21974.0±1587)、(42651.2±1336)和(87736.8±1938)ng/(L· min)。结论单次皮下注射rhPTH(1-84)在低、中、高3个剂量内,Cmax、AUC(0-∞)在2组动物中均呈线性代谢特征,模型组双峰特征明显,可以为设计和优化临床研究及给药方案提供重要信息。
英文摘要:
      Objective To study the pharmacokinetic characteristics of injected recombinant human parathyroid hormone rhPTH (1-84) in ovariectomized rats with osteoporosis.Methods Forty-eight rats, with an average weight of 250 ±10g, were randomly divided into control group ( small piece of adipose tissue around the ovary was removed ) and model group ( bilateral ovariectomy was performed), and each group had 8 rats.At the 4th week after the surgery, rats received a subcutaneous injection of 1μg/kg, 2μg/kg, or 4 μg/kg rhPTH ( 1-84 ) , respectively .The plasma concentration of rhPTH ( 1-84 ) at different time points was determined using radioimmunoassay method .The pharmacokinetic parameters were calculated .Results Excellent linear correlation was showed within the range of 24-1850 pg/mL.The minimum detection of rhPTH (1-84) in plasma was 10 pg/mL.The extraction efficiency in plasma was within the range of 80.2-90.6%.The AUC (0-∞), a pharmacokinetic parameter, in low, middle, and high dose model group was 24628.9 ±1281, 47059.3 ±3311, and 96652.1 ±2174 ng/L· min, respectively.The AUC (0-∞) in control group was 21974.0 ±1587, 42651.2 ±1336, and 87736.8 ±1938 ng/L· min, respectively.Conclusion After the single injection of low, middle, and high dose of rhPTH(1-84), the Cmax and ACU (0-∞) in both groups show a linear metabolic characteristics . The plasma concentration time curves show a clear bimodal in model groups , which can provide important information for the drug design and optimization of clinical research .
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=076BE44BE4A38F02805260DBB4EDAB97118C00F327CE77FC8FB27CA8A94B1A4B49AA3245EF8A2C48814CB3A56D36CDF8F302F042363E49FF3131C67F62834405815B1D68DE7B13B49AA2A9699EE6FE971DA03267935E5208FA72288175B58563800342DC42A253595F8B06871EE0F72E&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=FF7AA908D58E97FA&aid=BA5D0854523CBF81A2ABFC1152C4FD67&vid=&iid=59906B3B2830C2C5&sid=880C4253794026AD&eid=83BD01456E8187CE&fileno=201312005&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="FF7AA908D58E97FA"; var my_aid="BA5D0854523CBF81A2ABFC1152C4FD67";